Musaffa Logo

Our certifications

Independent proof that every stock and portfolio meets halal standards.

How we screen every stock
METHODOLOGY

How we screen every stock

Our 5-step halal methodology, in 90 seconds.

CVM Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: June 17, 2026

Report Source: 2026 2nd Quarter Report

Analyst's Ratings for CEL-SCI Corp (CVM)

Based on 5 analysts giving stock ratings to CEL-SCI Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
20
Buy
60
Hold
20
Sell
0
Strong Sell
0
CEL-SCI Corp

CEL-SCI Corp. Stock Analysis CVM

United States Health Care Nano Cap Report:
CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. The company is headquartered in Vienna, Virginia. The company is engaged in research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body’s natural defense system. The company is focused on the development of product candidates and technologies, including Multikine and Ligand Epitope Antigen Presentation System technology (LEAPS). Multikine (Leukocyte Interleukin, Injection), a true first-line cancer therapy, which is designed to help the immune system target the tumor at a time when the immune system is still relatively intact and thereby thought to be better able to mount an attack on the tumor. LEAPS is designed to stimulate the human immune system to more effectively fight bacterial, viral and parasitic infections as well as autoimmune conditions, allergies, transplantation rejection and cancer, when it cannot do so on its own. The LEAPS candidates include CEL-2000, CEL-4000 and DerG-PG275(Cit) (aka, CEL-5000).
Read More

CEL-SCI Corp (CVM) Chart

Key Statistics of CEL-SCI Corp (CVM)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.02$1.16

Today's Open

$1.03

Volume

189.88K

P/E Ratio (TTM)

-

52 Week Range

$0.89$13.48

Market Cap

12.32M

Avg. Volume

345.05K

Dividend Yield

-

Financial Metrics & Statements of CEL-SCI Corp (CVM)

FAQ's for CEL-SCI Corp (CVM)

  • According to Musaffa’s Shariah screening methodology, CEL-SCI Corp (CVM) is currently classified as NOT HALAL as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CEL-SCI Corp using these criteria to determine its compliance status.
  • Muslim investors may consider investing in CEL-SCI Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of CEL-SCI Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of CEL-SCI Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of CEL-SCI Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.